The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage

Cell Death and Differentiation

Volumn 16, Issue 12, 2009, Pages 1641-1653

  Cassimere, E K ^a,b   Pyndiah, S ^a   Sakamuro, D ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BIN1 PROTEIN; ETOPOSIDE; PROTEIN P53; PROTEIN P73; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; HUMANS; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 70449707449     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.98     Document Type: Article

References (42)

1. Kovesdi I, Reichel R, Nevins JR. E1A transcription induction: Enhanced binding of a factor to upstream promoter sequences. Science 1986; 231: 719-722.
2. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995; 15: 4215-4224.
3. Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ, Johnson DG. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci USA 1998; 95: 8858-8863.
4. Weinberg RA. E2F and cell proliferation: A world turned upside down. Cell 1996; 85: 457-459.
5. Phillips AC, Vousden KH. E2F-1 induced apoptosis. Apoptosis 2001; 6: 173-182.
6. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 2007; 19: 649-657.
7. Polager S, Ginsberg D. E2F - at the crossroads of life and death. Trends Cell Biol 2008; 18: 528-535.
8. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996; 85: 537-548.
9. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
10. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 1996; 14: 69-77.
11. Sakamuro D, Prendergast GC. New Myc-interacting proteins: A second Myc network emerges. Oncogene 1999; 18: 2942-2954.
12. Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P et al. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Oncogene 1999; 18: 3564-3573.
13. DuHadaway JB, Sakamuro D, Ewert DL, Prendergast GC. Bin1 mediates apoptosis by c-Myc in transformed primary cells. Cancer Res 2001; 61: 3151-3156.
14. Elliott K, Ge K, Du W, Prendergast GC. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 2000; 19: 4669-4684.
15. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001; 15: 1833-1844.
16. Ge K, Duhadaway J, Sakamuro D, Wechsler-Reya R, Reynolds C, Prendergast GC. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity. Int J Cancer 2000; 85: 376-383.
17. Ge K, Minhas F, Duhadaway J, Mao NC, Wilson D, Buccafusca R et al. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000; 86: 155-161.
18. Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, Prendergast GC. Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 1999; 96: 9689-9694.
19. Prendergast GC, Muller AJ, Ramalingam A, Chang MY. BAR the door: Cancer suppression by amphiphysin-like genes. Biochim Biophys Acta 2009; 1795: 25-36.
20. Wechsler-Reya R, Sakamuro D, Zhang J, DuHadaway J, Prendergast GC. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem 1997; 272: 31453-31458.
21. Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. J Cell Physiol 2008; 216: 621-631.
22. Hardy S, Shenk T. E2F from adenovirus-infected cells binds cooperatively to DNA containing two properly oriented and spaced recognition sites. Mol Cell Biol 1989; 9: 4495-4506.
23. Attwooll C, Lazzerini-Denchi E, Helin K. The E2F family: Specific functions and overlapping interests. EMBO J 2004; 23: 4709-4716.
24. Pineda-Lucena A, Ho CS, Mao DY, Sheng Y, Laister RC, Muhandiram R et al. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. J Mol Biol 2005; 351: 182-194.
25. Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate. J Biol Chem 2002; 277: 11617-11620.
26. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 1995; 11: 2411-2418.
27. Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 2001; 8: 105-113.
28. Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 2004; 431: 712-717.
29. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132: 363-374.
30. Frisch SM. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc Natl Acad Sci USA 1991; 88: 9077-9081.
31. Frisch SM. E1a induces the expression of epithelial characteristics. J Cell Biol 1994; 127: 1085-1096.
32. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626.
33. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-383.
34. Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000; 19: 3823-3828.
35. Drees BL, Sundin B, Brazeau E, Caviston JP, Chen GC, Guo W et al. A protein interaction map for cell polarity development. J Cell Biol 2001; 154: 549-571.
36. Routhier EL, Donover PS, Prendergast GC. Hob1+, the fission yeast homolog of Bin1, is dispensable for endocytosis or actin organization, but required for the response to starvation or genotoxic stress. Oncogene 2003; 22: 637-648.
37. Zelhof AC, Bao H, Hardy RW, Razzaq A, Zhang B, Doe CQ. Drosophila Amphiphysin is implicated in protein localization and membrane morphogenesis but not in synaptic vesicle endocytosis. Development 2001; 128: 5005-5015.
38. Lebowitz PF, Sakamuro D, Prendergast GC. Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment. Cancer Res 1997; 57: 708-713.
39. DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM et al. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1. Oncogene 2003; 22 3578-3588.
40. Javier RT. Cell polarity proteins: Common targets for tumorigenic human viruses. Oncogene 2008; 27: 7031-7046.
41. Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res 2007; 67: 100-107.
42. Chang MY, Boulden J, Katz JB, Wang L, Meyer TJ, Soler AP et al. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res 2007; 67: 7605-7612.